News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,341 Results
Type
Article (14288)
Company Profile (281)
Press Release (254772)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79586)
Career Advice (153)
Deals (13241)
Drug Delivery (35)
Drug Development (50474)
Employer Resources (31)
FDA (5731)
Job Trends (5145)
News (144520)
Policy (10039)
Tag
Academia (916)
Accelerated approval (3)
Adcomms (13)
Allergies (52)
Alliances (21690)
ALS (69)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (110)
Approvals (5757)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4562)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (61)
Brain cancer (20)
Breast cancer (164)
Cancer (1544)
Cardiovascular disease (122)
Career advice (134)
Career pathing (2)
CAR-T (127)
Cell therapy (349)
Cervical cancer (9)
Clinical research (41208)
Collaboration (568)
Compensation (284)
Complete response letters (13)
COVID-19 (1035)
CRISPR (46)
C-suite (173)
Cystic fibrosis (78)
Data (1650)
Denatured (11)
Depression (32)
Diabetes (146)
Diagnostics (1305)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (88)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (95)
Earnings (30285)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48892)
Executive appointments (478)
FDA (6516)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (522)
Gene editing (104)
Generative AI (10)
Gene therapy (273)
GLP-1 (375)
Government (1084)
Grass and pollen (2)
Guidances (75)
Healthcare (6601)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1102)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7287)
IRA (11)
Job creations (865)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1391)
Liver cancer (34)
Lung cancer (212)
Lymphoma (107)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (65)
Medical device (2621)
Medtech (2622)
Mergers & acquisitions (6297)
Metabolic disorders (416)
Multiple sclerosis (55)
NASH (13)
Neurodegenerative disease (77)
Neuropsychiatric disorders (26)
Neuroscience (1289)
NextGen: Class of 2025 (2023)
Non-profit (853)
Now hiring (23)
Obesity (201)
Opinion (103)
Ovarian cancer (67)
Pain (46)
Pancreatic cancer (60)
Parkinson's disease (126)
Partnered (8)
Patents (140)
Patient recruitment (84)
Peanut (35)
People (25700)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14564)
Phase II (19175)
Phase III (12104)
Pipeline (1000)
Policy (49)
Postmarket research (852)
Preclinical (6171)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (302)
Real estate (1419)
Recruiting (12)
Regulatory (8683)
Reports (18)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (7)
RSV (10)
Schizophrenia (64)
Series A (103)
Series B (70)
Service/supplier (1)
Sickle cell disease (43)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (218)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (149)
Last 7 days (627)
Last 30 days (2096)
Last 365 days (19363)
2025 (7421)
2024 (20560)
2023 (22428)
2022 (26829)
2021 (27819)
2020 (23367)
2019 (16247)
2018 (11744)
2017 (13749)
2016 (11841)
2015 (14349)
2014 (10396)
2013 (7487)
2012 (7532)
2011 (7615)
2010 (7428)
Location
Africa (148)
Alabama (44)
Alaska (2)
Arizona (53)
Arkansas (6)
Asia (17402)
Australia (2948)
California (4175)
Canada (1194)
China (379)
Colorado (159)
Connecticut (157)
Delaware (111)
Europe (37394)
Florida (507)
Georgia (128)
Idaho (16)
Illinois (245)
India (10)
Indiana (94)
Iowa (3)
Japan (83)
Kansas (64)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (501)
Massachusetts (3313)
Michigan (75)
Minnesota (155)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1021)
New Mexico (12)
New York (1108)
North Carolina (578)
North Dakota (6)
Northern California (1869)
Ohio (118)
Oklahoma (9)
Oregon (21)
Pennsylvania (781)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1594)
Tennessee (26)
Texas (483)
United States (14191)
Utah (56)
Virginia (87)
Washington D.C. (31)
Washington State (369)
Wisconsin (19)
269,341 Results for "spero therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
April 28, 2025
·
4 min read
Press Releases
Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
May 14, 2025
·
8 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025
May 5, 2025
·
1 min read
Press Releases
Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update
March 28, 2025
·
12 min read
Press Releases
Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
·
1 min read
Press Releases
UPDATE – Spero Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
February 25, 2025
·
1 min read
Press Releases
Spero Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 27, 2025
March 19, 2025
·
1 min read
Press Releases
Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
January 13, 2025
·
13 min read
Deals
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics, Inc. today announced that on May 28, 2024, the Compensation Committee of Spero’s Board of Directors approved the grant of 116,667 restricted stock unit awards (RSUs) to a new employee.
June 3, 2024
·
2 min read
1 of 26,935
Next